D
Phathom Pharmaceuticals, Inc. PHAT
$4.41 $0.194.50%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -74.45M -85.58M -91.45M -82.85M -79.57M
Total Depreciation and Amortization 193.00K 191.00K 197.00K 214.00K 185.00K
Total Amortization of Deferred Charges 629.00K 346.00K 743.00K 474.00K 566.00K
Total Other Non-Cash Items 19.21M 20.08M 20.41M 20.17M 34.35M
Change in Net Operating Assets -9.04M 1.39M -626.00K -7.02M 676.00K
Cash from Operations -63.46M -63.57M -70.72M -69.02M -43.80M
Capital Expenditure -5.00K -44.00K -46.00K -40.00K -475.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -5.00K -44.00K -46.00K -40.00K -475.00K
Total Debt Issued 24.75M 0.00 24.75M 9.90M 211.99M
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 1.30M 122.06M 21.00K -- 0.00
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 26.05M 122.06M 24.77M 9.90M 211.99M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -37.42M 58.44M -46.00M -59.16M 167.72M
Weiss Ratings